About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 60 women aged 18 to 34 at high OHSS risk, Hammersmith Hospital IVF unit, London
- Sample size
- 60
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 13 August 2026
Limitations
Single-centre; open-label design; no direct active-comparator arm within this specific trial; small sample per dose-arm.
Cited in
Oocyte maturation in IVF
Kisspeptin · Research finding
LimitedIVF trial complications, 60 women
Kisspeptin · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.